<p>(A) Soft agar colony formation assay was performed in K562 cells after treatment with NC (4 μM), IM (0.2 μM) or both. Colonies >0.1 mm in diameter were counted under a microscopic bright field at 50× magnification. One representative picture was shown. Columns represented means ± S.E. (n = 3). **, <i>P</i><0.01. ***, <i>P</i><0.001. (B) Apoptosis rate was detected by annexin V/PI double staining after K562 or K562/G01 cells were treated with NC (4 μM), IM (0.2 μM) or NC+IM for 48 hrs. (C) BMMCs from 5 CML patients were treated with NC (4 μM), IM (0.5 μM) or NC+IM for 48 hrs, and annexin V/PI double staining was used to detect apoptotic rate. (D) BMMCs from three CML patients (P1, P2 and P4) were treated with 0, 4 or 8 μM NC for 2 days. c...
<p><b>(A-B)</b> C57Bl/6 mice were treated with imatinib at 66 mg/kg/d or water for 7d prior to infec...
<p><b>Objective:</b> In chronic myeloid leukemia (CML), imatinib mesylate (IM; Gle...
<p>(A): A549 cells were treated with Gemcitabine for 24h then miR10b, miR20a, miR34c and miR106 expr...
<p>(A) After K562 cells were treated with 4 or 8 μM NC for 24 or 48 hrs, MTT assay was performed to ...
<p>(A) Cells were treated with MX (0.6 µM), DXR (0.8 µM), imatinib (5 µM) or their combinations for ...
<p>C57Bl/6 mice were administered imatinib at 66 mg/kg/d or left untreated. Beginning 24h post-treat...
<p>(<b>A</b>) Apoptotic rates between LSCs and BCR-ABL expressing LSK<sup>−</sup> cells in CML mice ...
<p>(<b>A</b>) Dose-effect of imatinib exposure (0–5 µM) for 6 days on CML-iPSC clones #1.22 and #1.3...
International audienceChronic myelogenous leukemia (CML) is a cytogenetic disorder resulting from th...
<p>(A) MNCs from CML patients were cultured with rh stem cell factor, rh IL-3, rh GM-CSF with or wit...
<p><b>(A)</b> Colony forming cell (CFC) assays with bone marrow derived from mice treated with imati...
<p>(<b>A</b>) Nuclear lysates from doxorubin (0.5 µM-top; 1 µM-bottom)/imatinib (10 µM)-treated 435s...
<p>(<b>A</b>) 435s/M14 cells, transfected with STAT3 siRNA, were drug treated (8 h), and nuclear fra...
<p>(<b>A</b>) 32Dp210 cells were cultured for 24 h with 0.5 µM etoposide (Etop.), 0.6 µM imatinib, o...
<p>(A) K562 cells were pretreated with 10 nM ACM in combination without or with 2 µM SB202190 (SB) f...
<p><b>(A-B)</b> C57Bl/6 mice were treated with imatinib at 66 mg/kg/d or water for 7d prior to infec...
<p><b>Objective:</b> In chronic myeloid leukemia (CML), imatinib mesylate (IM; Gle...
<p>(A): A549 cells were treated with Gemcitabine for 24h then miR10b, miR20a, miR34c and miR106 expr...
<p>(A) After K562 cells were treated with 4 or 8 μM NC for 24 or 48 hrs, MTT assay was performed to ...
<p>(A) Cells were treated with MX (0.6 µM), DXR (0.8 µM), imatinib (5 µM) or their combinations for ...
<p>C57Bl/6 mice were administered imatinib at 66 mg/kg/d or left untreated. Beginning 24h post-treat...
<p>(<b>A</b>) Apoptotic rates between LSCs and BCR-ABL expressing LSK<sup>−</sup> cells in CML mice ...
<p>(<b>A</b>) Dose-effect of imatinib exposure (0–5 µM) for 6 days on CML-iPSC clones #1.22 and #1.3...
International audienceChronic myelogenous leukemia (CML) is a cytogenetic disorder resulting from th...
<p>(A) MNCs from CML patients were cultured with rh stem cell factor, rh IL-3, rh GM-CSF with or wit...
<p><b>(A)</b> Colony forming cell (CFC) assays with bone marrow derived from mice treated with imati...
<p>(<b>A</b>) Nuclear lysates from doxorubin (0.5 µM-top; 1 µM-bottom)/imatinib (10 µM)-treated 435s...
<p>(<b>A</b>) 435s/M14 cells, transfected with STAT3 siRNA, were drug treated (8 h), and nuclear fra...
<p>(<b>A</b>) 32Dp210 cells were cultured for 24 h with 0.5 µM etoposide (Etop.), 0.6 µM imatinib, o...
<p>(A) K562 cells were pretreated with 10 nM ACM in combination without or with 2 µM SB202190 (SB) f...
<p><b>(A-B)</b> C57Bl/6 mice were treated with imatinib at 66 mg/kg/d or water for 7d prior to infec...
<p><b>Objective:</b> In chronic myeloid leukemia (CML), imatinib mesylate (IM; Gle...
<p>(A): A549 cells were treated with Gemcitabine for 24h then miR10b, miR20a, miR34c and miR106 expr...